Porcine Vaccines Market Highlights

The porcine vaccine market is estimated to grow crucially over the expected period. The porcine vaccines market had a market value of USD 2,429.76 Million in 2030 and is expected to grow at CAGR of 7.20% over 2022 to 2030.

The Porcine Vaccines Market is a critical segment of the global veterinary pharmaceutical industry, dedicated to safeguarding the health and productivity of swine populations worldwide. These vaccines are designed to prevent and control a wide range of diseases that affect pigs, including swine flu, porcine reproductive and respiratory syndrome (PRRS), and classical swine fever. The market has witnessed steady growth due to rising concerns about food safety, increased pork consumption, and the economic importance of the swine industry. Advancements in vaccine technology, such as DNA-based and subunit vaccines, are driving innovation. Additionally, the growing emphasis on animal welfare and disease prevention further fuels market expansion as farmers seek efficient and sustainable solutions to protect their herds. However, challenges like regulatory hurdles and vaccine development costs persist in this dynamic market. Overall, the Porcine Vaccines Market is poised for continued growth as the global swine industry seeks to address health challenges and ensure a safe and abundant pork supply.

Top of Form

However, high cost of maintaining vaccines may hamper the market growth during the assessment period.

Segmentation

The global porcine vaccines market research report has been segmented into type, disease indication, and end user.

By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.

Based on disease indication, the global porcine vaccines market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.

The global porcine vaccines market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global porcine vaccines market owing to the increasing prevalence of porcine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive Respiratory Syndrome), swine influenza etc. and rapid increase in pig farms.  Additionally, rise in number of contract farming and independent farming for pig cultivation is contributing the market growth. According to The United States Department of Agriculture, National Agricultural Statistics Service “Livestock Slaughter” report, U.S. pork production was around 2 billion pound in 2016. Europe is expected to hold the second largest position in the global porcine vaccines market owing to increasing number of production units for pigs and high consumption of pork meat. The Asia-Pacific region is anticipated to be fastest growing region is due to introduction of new vaccines, initiatives by various government agencies, animal care associations, and incidence of major key players for growth and development in this region. The Middle East Africa has the least global porcine vaccines market share. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the agriculture and animal husbandry sector.

Porcine Vaccines Market Players

The global porcine vaccines market players are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck Co., Inc., Sanofi S.A., Vetoquinol S.A., Zoetis, Inc., PBS Animal Health, Aptimmune.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com